MARKET INSIGHTS
Global Graphene Quantum Dot (GQD) for Bioimaging market size was valued at USD 187.4 million in 2025. The market is projected to grow from USD 213.6 million in 2026 to USD 741.2 million by 2034, exhibiting a CAGR of 14.8% during the forecast period.
Graphene Quantum Dots (GQDs) are nanoscale fragments of graphene, typically ranging from 2 to 20 nanometers in size, characterized by their exceptional photoluminescence, low cytotoxicity, and superior biocompatibility. In the context of bioimaging, GQDs serve as highly efficient fluorescent probes, enabling high-resolution visualization of cellular structures, tumor microenvironments, and biological processes at the molecular level. Their tunable optical properties, chemical stability, and surface functionalization capabilities make them a compelling alternative to conventional semiconductor quantum dots and organic dyes.
The market is gaining strong momentum driven by the rising prevalence of cancer and chronic diseases necessitating advanced diagnostic imaging tools, alongside growing investments in nanotechnology-based medical research. Furthermore, the expanding adoption of GQDs in multimodal bioimaging platforms – combining fluorescence with photoacoustic and MRI imaging – is broadening their clinical applicability. Key players actively operating in this space include Merck KGaA, Sigma‑Aldrich (MilliporeSigma), Dotz Nano Ltd., and Graphene 3D Lab, among others contributing to a rapidly evolving competitive landscape.
Graphene Quantum Dot (GQD) for Bioimaging Market – View in Detailed Research Report
🔟 1. Merck KGaA
Headquarters: Darmstadt, Germany
Key Offering: GQD‑based fluorescent probes and functionalized nanomaterials for biomedical imaging
Merck KGaA has leveraged its extensive chemistry platform to develop high‑purity, surface‑functionalized GQDs that exhibit quantum yields above 60% in aqueous media. These probes enable multicolor cellular imaging with minimal photobleaching, supporting real‑time tracking of tumor microenvironments.
Sustainability & Growth Initiatives:
- Investing in green synthesis routes using citric acid and renewable feedstocks.
- Partnerships with academic institutions for clinical translation of GQD imaging agents.
- Expansion of product portfolio into theranostic applications combining imaging and photodynamic therapy.
9️⃣ 2. Sigma‑Aldrich (Merck KGaA)
Headquarters: Darmstadt, Germany
Key Offering: Research‑grade GQDs and conjugation kits for targeted imaging
Sigma‑Aldrich supplies a range of functionalized GQDs with customizable surface chemistry, facilitating antibody conjugation and aptamer attachment for tumor‑specific imaging. Their products are widely adopted in academic laboratories worldwide.
Sustainability & Growth Initiatives:
- Development of low‑toxicity synthesis protocols to meet regulatory expectations.
- Collaboration with biotech firms to integrate GQDs into multimodal imaging platforms.
- Launch of a digital platform for GQD data sharing and protocol standardization.
8️⃣ 3. Dotz Nano Ltd.
Headquarters: Sydney, Australia / Israel
Key Offering: Coal‑derived GQDs with high quantum yield and robust surface functionalization
Dotz Nano’s proprietary synthesis from coal‑based feedstocks yields GQDs with narrow size distribution and quantum yields exceeding 55%. The company focuses on scalable production for both research and early‑clinical applications.
Sustainability & Growth Initiatives:
- Implementation of closed‑loop waste management in synthesis plants.
- Strategic alliances with pharmaceutical companies for theranostic pipeline development.
- Investment in AI‑driven design of surface ligands for targeted delivery.
7️⃣ 4. Graphene 3D Lab
Headquarters: Singapore
Key Offering: 3D‑structured GQD composites for enhanced imaging contrast and drug delivery
Graphene 3D Lab engineers three‑dimensional GQD architectures that provide amplified fluorescence and improved photostability. These materials are tailored for deep‑tissue imaging and controlled drug release.
Sustainability & Growth Initiatives:
- Development of biodegradable GQD scaffolds for tissue imaging.
- Partnerships with medical device manufacturers for intraoperative imaging solutions.
- Exploration of near‑infrared (NIR) doped GQDs for deep‑tissue diagnostics.
6️⃣ 5. ACS Material LLC
Headquarters: Northbrook, USA
Key Offering: High‑purity, functionalized GQDs for life‑sciences research
ACS Material supplies research‑grade GQDs with customizable surface chemistries, supporting a wide range of imaging modalities from fluorescence to photoacoustic imaging.
Sustainability & Growth Initiatives:
- Adoption of solvent‑free synthesis processes.
- Collaboration with universities for standardization of GQD characterization.
- Investment in scalable production lines to reduce per‑unit cost.
5️⃣ 6. Sigma‑Aldrich (Merck KGaA)
Headquarters: Darmstadt, Germany
Key Offering: Commercial GQD reagents for diagnostics and imaging research
In addition to research products, Sigma‑Aldrich offers GQD kits for diagnostic laboratories, enabling rapid adoption of carbon‑based imaging agents.
Sustainability & Growth Initiatives:
- Integration of renewable energy in production facilities.
- Development of standardized quality metrics for GQD batches.
- Partnerships with regulatory bodies to streamline approval pathways.
4️⃣ 7. Graphene Platform Corporation
Headquarters: Tokyo, Japan
Key Offering: Direct GQD synthesis platform for high‑performance imaging probes
Graphene Platform’s in‑house synthesis delivers GQDs with precise size control and surface functionalization, supporting high‑resolution cellular and in‑vivo imaging.
Sustainability & Growth Initiatives:
- Use of low‑temperature hydrothermal processes to reduce energy consumption.
- Collaboration with Japanese research institutes for NIR‑GQD development.
- Expansion of product line into magnetic resonance imaging (MRI) contrast agents.
3️⃣ 8. Graphenea S.A.
Headquarters: Madrid, Spain
Key Offering: Graphene‑derived GQDs for biomedical research and diagnostics
Graphenea focuses on high‑quality graphene films and extends its expertise to GQD production, offering materials with consistent photoluminescence properties.
Sustainability & Growth Initiatives:
- Investments in EU “Graphene Flagship” research programs.
- Partnerships with European pharmaceutical companies for theranostic trials.
- Implementation of circular‑economy principles in raw‑material sourcing.
2️⃣ 9. Nanjing MKNANO Tech Co., Ltd.
Headquarters: Nanjing, China
Key Offering: Bio‑compatible GQDs with customizable surface chemistry for diagnostics
The company supplies GQDs that meet stringent biocompatibility standards, enabling their use in preclinical imaging studies.
Sustainability & Growth Initiatives:
- Adoption of green chemistry practices in synthesis.
- Collaboration with Chinese universities for clinical validation.
- Expansion into NIR‑emitting GQDs for deep‑tissue imaging.
1️⃣ 10. Strem Chemicals, Inc. (Ascensus Specialties)
Headquarters: New York, USA
Key Offering: High‑purity GQDs and functionalization reagents for advanced imaging
Strem Chemicals supplies GQDs with rigorous quality control, supporting research into multimodal imaging and drug‑delivery tracking.
Sustainability & Growth Initiatives:
- Implementation of low‑VOC synthesis protocols.
- Strategic partnerships with biotech firms for theranostic platform development.
- Investment in scalable purification technologies to lower costs.
Download FREE Sample Report: Graphene Quantum Dot (GQD) for Bioimaging Market – View in Detailed Research Report
Get Full Report: Graphene Quantum Dot (GQD) for Bioimaging Market – View in Detailed Research Report
Market Outlook
With a projected CAGR of 14.8% from 2026 to 2034, the GQD for Bioimaging market is poised for rapid expansion. The convergence of increasing cancer incidence, the demand for real‑time, high‑resolution imaging, and the growing adoption of multimodal platforms will drive market penetration. Regulatory acceptance of carbon‑based nanomaterials and continued investment in synthesis and surface‑functionalization technologies are expected to accelerate the transition from research to clinical application, expanding market share across North America, Europe, and Asia‑Pacific.
Emerging Trends
- Multimodal imaging platforms that integrate GQDs with photoacoustic, MRI, and PET modalities.
- Targeted drug‑delivery systems leveraging surface‑functionalized GQDs for theranostic applications.
- Near‑infrared (NIR) GQDs engineered through heteroatom doping to enable deep‑tissue imaging.
- Scalable, green synthesis routes that reduce production cost and environmental impact.
- Standardization of quality benchmarks and regulatory frameworks for carbon‑based nanomaterials.
- Top 10 Companies in the Global Textile Composites Market (2026): Market Leaders Powering Innovation - June 21, 2026
- Top 10 Companies in the Global Timber Connectors Market (2026): Market Leaders Powering Construction - June 21, 2026
- Top 10 Companies in the Global Brazing Rod Materials Market (2026): Market Leaders Powering Global Manufacturing - June 21, 2026